Myositis

Core Outcome Set

Explore outcome domains, measurement options and the evidence

behind the Myositis core outcome set.

COS Logos
About this core outcome set

The myositis life impact core domain set identifies a minimum set of outcome domains to measure and report in clinical trials of adult idiopathic inflammatory myopathies (IIM). Using a standardized set helps researchers compare findings across studies and understand the effects of interventions.

This set focuses on the life impact of myositis and complements the International Myositis Assessment and Clinical Studies (IMACS) core set, which focuses on disease activity and damage. It was developed with strong patient participation through focus groups and three Delphi surveys with several hundred patients, caregivers, and healthcare providers from five countries.

At OMERACT 2018, more than 85% of participants endorsed muscle symptoms, fatigue, level of physical activity, and pain as mandatory for all trials. Lung, joint, and skin symptoms are mandatory in specific circumstances, since they apply to particular disease subsets.

The working group is now selecting instruments, and studies of the PROMIS pain interference, fatigue, and physical function measures in adults with myositis have shown good content validity, reliability, and responsiveness.

OMERACT_Endorsed Onions
CDS Tables (2)

Learn how OMERACT develops core outcome sets

Scroll to Top